Literature DB >> 16802330

EphA4 regulates central nervous system vascular formation.

Yona Goldshmit1, Mary P Galea, Perry F Bartlett, Ann M Turnley.   

Abstract

Molecules involved in axon guidance have recently also been shown to play a role in blood vessel guidance. To examine whether axon guidance molecules, such as the EphA4 receptor tyrosine kinase, might also play a role in development of the central nervous system (CNS) vasculature and repair following CNS injury, we examined wild-type and EphA4 null mutant (-/-) mice. EphA4-/- mice exhibited an abnormal CNS vascular structure in both the cerebral cortex and the spinal cord, with disorganized branching and a 30% smaller diameter. During development, EphA4 was expressed on endothelial cells. This pattern of expression was not maintained in the adult. After spinal cord injury in wild-type mice, expression of EphA4 was markedly up-regulated on activated astrocytes, many of which were tightly associated with blood vessels. In EphA4-/- spinal cord following injury, astrocytes were not as tightly associated with blood vessels as the wild-type astrocytes. In uninjured EphA4-/- mice, the blood-brain barrier (BBB) appeared normal, but it showed prolonged leakage following spinal cord injury. These results support a role for EphA4 in CNS vascular formation and guidance during development and an additional role in BBB repair. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16802330     DOI: 10.1002/cne.21029

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  15 in total

Review 1.  Glial regulation of the blood-brain barrier in health and disease.

Authors:  Bieke Broux; Elizabeth Gowing; Alexandre Prat
Journal:  Semin Immunopathol       Date:  2015-08-06       Impact factor: 9.623

2.  Characterization of axons expressing the artemin receptor in the female rat urinary bladder: a comparison with other major neuronal populations.

Authors:  Shelley L Forrest; Peregrine B Osborne; Janet R Keast
Journal:  J Comp Neurol       Date:  2014-07-24       Impact factor: 3.215

Review 3.  Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy.

Authors:  Abbas Mirshafiey; Ghasem Ghalamfarsa; Babak Asghari; Gholamreza Azizi
Journal:  Innov Clin Neurosci       Date:  2014-07

4.  A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors.

Authors:  Roberta Noberini; Surya K De; Ziming Zhang; Bainan Wu; Dhanya Raveendra-Panickar; Vida Chen; Jesus Vazquez; Haina Qin; Jianxing Song; Nicholas D P Cosford; Maurizio Pellecchia; Elena B Pasquale
Journal:  Chem Biol Drug Des       Date:  2011-09-06       Impact factor: 2.817

5.  The Ephrin-A5/EphA4 Interaction Modulates Neurogenesis and Angiogenesis by the p-Akt and p-ERK Pathways in a Mouse Model of TLE.

Authors:  Yi Shu; Bo Xiao; Qian Wu; Tiantian Liu; Yang Du; Haiyun Tang; Si Chen; Li Feng; Lili Long; Yi Li
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

6.  Generation of an EphA4 conditional allele in mice.

Authors:  Julia E Herrmann; Morgan A Pence; Emanuel A Shapera; Ravi R Shah; Cédric G Geoffroy; Binhai Zheng
Journal:  Genesis       Date:  2010-02       Impact factor: 2.487

7.  PADPIN: protein-protein interaction networks of angiogenesis, arteriogenesis, and inflammation in peripheral arterial disease.

Authors:  Liang-Hui Chu; Chaitanya G Vijay; Brian H Annex; Joel S Bader; Aleksander S Popel
Journal:  Physiol Genomics       Date:  2015-06-09       Impact factor: 3.107

Review 8.  White matter inhibitors in CNS axon regeneration failure.

Authors:  Fang Xie; Binhai Zheng
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

9.  Vitamin D deficiency leads to sensory and sympathetic denervation of the rat synovium.

Authors:  S E Tague; P G Smith
Journal:  Neuroscience       Date:  2014-09-02       Impact factor: 3.590

10.  Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling.

Authors:  Hilary A North; Xiumei Zhao; Sharon M Kolk; Meredith A Clifford; Daniela M Ziskind; Maria J Donoghue
Journal:  Development       Date:  2009-07       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.